The humble aspirin may soon have a new role. Scientists have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than the classic ...

The delayed-release aspirin compound that Pozen (NASDAQ:POZN) has developed to protect against cardiovascular disease showed in clinical trials that it causes fewer ulcers compared to aspirin alone.

An interdisciplinary team of researchers at the Indian Institute of Science has designed a novel chemical compound that can be tailored to release aspirin over a desired duration inside the body. It ...

Popping aspirin on a regular basis may cut your risk of dying from cancer. People who took the over-the-counter drug for several years were 21% less likely to die of stomach, esophageal and lung ...

A study in the Journal of Agricultural and Food Chemistry finds that humans can manufacture their own salicylic acid, the major part of aspirin. Another study, in Nature, shows that plants make their ...

ON AUGUST 10th 1897, Felix Hoffmann, a chemist in the employ of a German dyestuffs company called Bayer, managed to acetylate the phenol group of a compound called salicylic acid. Not, on the face of ...

The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent ...

The aspirin compound also shrank human colon cancer tumors by 85 percent in live animals, again without adverse effects, according to a second paper in press by the City College researchers and ...